ES2110544T3 - Procedimiento para la fabricacion de una preparacion a base de microesferas de liberacion sostenida. - Google Patents
Procedimiento para la fabricacion de una preparacion a base de microesferas de liberacion sostenida.Info
- Publication number
- ES2110544T3 ES2110544T3 ES93111455T ES93111455T ES2110544T3 ES 2110544 T3 ES2110544 T3 ES 2110544T3 ES 93111455 T ES93111455 T ES 93111455T ES 93111455 T ES93111455 T ES 93111455T ES 2110544 T3 ES2110544 T3 ES 2110544T3
- Authority
- ES
- Spain
- Prior art keywords
- water
- sustained release
- give
- active ingredient
- microspheres
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
UN METODO PARA PRODUCIR PREPARACION DE MICROESFERA MANTENIDA LIBRE PARA MEDICAMENTO SOLUBLE EN AGUA, EL CUAL TIENE ALTA EFICIENCIA DE INCORPORACION DEL MEDICAMENTO Y REDUCIDA EMISION INICIAL, EL CUAL COMPRENDE DISOLVER INGREDIENTE ACTIVO FARMACEUTICO SOLUBLE EN AGUA Y POLIMERO BIODEGRABLE INSOLUBLE EN AGUA EN UNO O DOS DISOLVENTES EN LOS CUALES AMBOS PUEDEN DISOLVERSE, ELIMINAR EL DISOLVENTE PARA DAR UNA DISPERSION SOLIDA QUE TIENE EL INGREDIENTE ACTIVO FARMACEUTICO SOLUBLE EN AGUA DISPERSADO EN DICHO POLIMERO BIODEGRADABLE A NIVEL MOLECULAR, Y ADICIONALMENTE, DISOLVER DICHA DISPERSION SOLIDA EN UN DISOLVENTE ORGANICO QUE SEA INMISCIBLE EN AGUA Y QUE TIENE UN PUNTO DE EBULLICION POR DEBAJO DE 100 ANTE EN UNA FASE ACUOSA QUE CONTIENE AGENTE EMULGENTE PARA DAR EMULSION O/W, Y SEGUIDO POR LA ELIMINACION DEL DISOLVENTE ORGANICO DESDE LA FASE DE ACEITE DE LA EMULSION RESULTANTE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4189181A JP2651320B2 (ja) | 1992-07-16 | 1992-07-16 | 徐放性マイクロスフェア製剤の製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2110544T3 true ES2110544T3 (es) | 1998-02-16 |
Family
ID=16236857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93111455T Expired - Lifetime ES2110544T3 (es) | 1992-07-16 | 1993-07-16 | Procedimiento para la fabricacion de una preparacion a base de microesferas de liberacion sostenida. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5556642A (es) |
EP (1) | EP0586838B1 (es) |
JP (1) | JP2651320B2 (es) |
KR (1) | KR100211435B1 (es) |
AT (1) | ATE159854T1 (es) |
CA (1) | CA2099941C (es) |
DE (1) | DE69315026T2 (es) |
DK (1) | DK0586838T3 (es) |
ES (1) | ES2110544T3 (es) |
GR (1) | GR3025297T3 (es) |
TW (1) | TW227988B (es) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9310030D0 (en) * | 1993-05-15 | 1993-06-30 | Scras | Dry processed particles and process for the preparation of the same |
US5650173A (en) * | 1993-11-19 | 1997-07-22 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of biodegradable microparticles containing a biologically active agent |
WO1995027481A1 (en) * | 1994-04-08 | 1995-10-19 | Atrix Laboratories, Inc. | Liquid delivery compositions |
ATE198152T1 (de) * | 1994-09-30 | 2001-01-15 | Takeda Chemical Industries Ltd | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe |
US5722950A (en) * | 1995-06-07 | 1998-03-03 | Atrix Laboratories, Inc. | Method for remote delivery of an aerosolized liquid |
US5877224A (en) * | 1995-07-28 | 1999-03-02 | Rutgers, The State University Of New Jersey | Polymeric drug formulations |
DE19545257A1 (de) | 1995-11-24 | 1997-06-19 | Schering Ag | Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln |
US5989463A (en) * | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
KR19990065921A (ko) * | 1998-01-19 | 1999-08-16 | 김충섭 | 항생제의서방성제제 |
KR20000022894A (ko) * | 1998-09-05 | 2000-04-25 | 이승진 | 생분해성 고분자 미립자형 제제 및 그 제조방법 |
US6143314A (en) * | 1998-10-28 | 2000-11-07 | Atrix Laboratories, Inc. | Controlled release liquid delivery compositions with low initial drug burst |
US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
US6328990B1 (en) * | 1999-11-12 | 2001-12-11 | The Trustees Of The University Of Pennsylvania | Bioactive, degradable composite for tissue engineering |
JP2001303434A (ja) * | 2000-04-24 | 2001-10-31 | Lion Corp | 光触媒含有スラリー |
ES2326209T3 (es) | 2000-10-27 | 2009-10-05 | Baxter Healthcare S.A. | Produccion de microesferas. |
WO2002049620A2 (en) | 2000-12-21 | 2002-06-27 | Inhale Therapeutic Systems, Inc. | Induced phase transition method for the production of microparticles containing hydrophobic active agents |
JP4510383B2 (ja) | 2001-05-23 | 2010-07-21 | 田辺三菱製薬株式会社 | 軟骨疾患修復治療用組成物 |
JP4510384B2 (ja) | 2001-05-23 | 2010-07-21 | 田辺三菱製薬株式会社 | 骨折治癒促進用組成物 |
EP1418890B1 (en) * | 2001-08-16 | 2008-05-14 | Baxter International Inc. | Propellant-based microparticle formulations |
CN1688275B (zh) * | 2002-09-11 | 2012-05-30 | 田边三菱制药株式会社 | 微球的制备方法 |
US20050003007A1 (en) * | 2003-07-02 | 2005-01-06 | Michele Boix | Method of sterilization of polymeric microparticles |
US20050142205A1 (en) * | 2003-07-18 | 2005-06-30 | Julia Rashba-Step | Methods for encapsulating small spherical particles prepared by controlled phase separation |
US20070092452A1 (en) * | 2003-07-18 | 2007-04-26 | Julia Rashba-Step | Methods for fabrication, uses, compositions of inhalable spherical particles |
KR101137785B1 (ko) * | 2003-07-18 | 2012-04-25 | 백스터 인터내셔널 인코포레이티드 | 제어된 상 분리에 의해 제조된 작은 구형 입자의 제조방법, 이용 방법 및 조성물 |
AU2004258971A1 (en) * | 2003-07-22 | 2005-02-03 | Baxter Healthcare S.A. | Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof |
MXPA06012992A (es) | 2004-05-12 | 2007-02-12 | Baxter Int | Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente. |
PT1765294E (pt) * | 2004-05-12 | 2008-12-30 | Baxter Healthcare Sa | Microesferas de ácido nucleico, sua produção e entrega |
US8728525B2 (en) | 2004-05-12 | 2014-05-20 | Baxter International Inc. | Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
CA2566199C (en) * | 2004-05-12 | 2013-10-22 | Baxter International Inc. | Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes |
CA2581143C (en) | 2004-09-21 | 2015-03-31 | Shandong Luye Pharmaceutical Co., Ltd. | Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
CN101188996B (zh) * | 2005-04-27 | 2013-03-27 | 巴克斯特国际公司 | 表面改性的微粒及其形成和使用方法 |
US20070281031A1 (en) * | 2006-06-01 | 2007-12-06 | Guohan Yang | Microparticles and methods for production thereof |
MX2009001226A (es) | 2006-08-04 | 2009-03-20 | Baxter Int | Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio. |
AU2007284759B2 (en) | 2006-08-09 | 2010-10-28 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
AU2007319577A1 (en) * | 2006-10-06 | 2008-05-22 | Baxter Healthcare S.A. | Microencapsules containing surface-modified microparticles and methods of forming and using the same |
WO2008064259A2 (en) * | 2006-11-21 | 2008-05-29 | Biokey, Inc. | Solid dispersion composition comprising fluvastatin |
AU2008244523B2 (en) | 2007-04-23 | 2012-02-16 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
WO2008135828A2 (en) | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
US8703204B2 (en) | 2007-05-03 | 2014-04-22 | Bend Research, Inc. | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer |
WO2008149192A2 (en) | 2007-06-04 | 2008-12-11 | Pfizer Products Inc. | Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
WO2008149230A2 (en) | 2007-06-04 | 2008-12-11 | Pfizer Products Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate |
US9724362B2 (en) | 2007-12-06 | 2017-08-08 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
US9233078B2 (en) | 2007-12-06 | 2016-01-12 | Bend Research, Inc. | Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
US8323685B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US8323615B2 (en) | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing multi-phasic dispersions |
US20100047292A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing microparticles and compositions produced thereby |
US8367427B2 (en) | 2008-08-20 | 2013-02-05 | Baxter International Inc. | Methods of processing compositions containing microparticles |
BRPI0918904B8 (pt) | 2008-09-04 | 2021-05-25 | Amylin Pharmaceuticals Inc | formulação pré-misturada fabricada para injeção, seu uso e kit compreendendo a mesma |
RU2547990C2 (ru) | 2009-09-28 | 2015-04-10 | Интарсия Терапьютикс, Инк. | Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства |
WO2011163469A1 (en) | 2010-06-23 | 2011-12-29 | Teva Pharmaceutical Industries Ltd. | Hydrated form of anti-inflammatory roflumilast-n-oxide |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
EP3302354B1 (en) | 2015-06-03 | 2023-10-04 | i2o Therapeutics, Inc. | Implant placement systems |
CN105878174B (zh) * | 2016-04-26 | 2021-06-29 | 广州帝奇医药技术有限公司 | 一种固体分散体及其制备方法与应用 |
CN105878190B (zh) * | 2016-04-26 | 2021-01-22 | 广州帝奇医药技术有限公司 | 缓释微粒的制备方法、制得的缓释微粒及其应用 |
CN105878191B (zh) * | 2016-04-26 | 2021-01-22 | 广州帝奇医药技术有限公司 | 缓释微粒的制备方法、制得的缓释微粒及其应用 |
CN105963257B (zh) * | 2016-04-26 | 2021-01-22 | 广州帝奇医药技术有限公司 | 一种缓释微粒的制备方法 |
CN105963258B (zh) | 2016-04-26 | 2021-01-22 | 广州帝奇医药技术有限公司 | 一种缓释微粒的制备方法 |
RU2760007C2 (ru) | 2016-05-16 | 2021-11-22 | Интарсия Терапьютикс, Инк. | Полипептиды, селективные к рецепторам глюкагона, и способы их применения |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
WO2018129058A1 (en) | 2017-01-03 | 2018-07-12 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug |
US20210154147A1 (en) * | 2018-10-19 | 2021-05-27 | Ac Pharmaceuticals Co., Ltd. | Preparation method of sustained-release microparticles |
KR20220104797A (ko) | 2019-11-25 | 2022-07-26 | 리제너론 파마슈티칼스 인코포레이티드 | 비수성 에멀전을 이용한 지속 방출 제형 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3976071A (en) * | 1974-01-07 | 1976-08-24 | Dynatech Corporation | Methods of improving control of release rates and products useful in same |
US4933105A (en) * | 1980-06-13 | 1990-06-12 | Sandoz Pharm. Corp. | Process for preparation of microspheres |
US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
PH19942A (en) * | 1980-11-18 | 1986-08-14 | Sintex Inc | Microencapsulation of water soluble polypeptides |
IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
US4479911A (en) * | 1982-01-28 | 1984-10-30 | Sandoz, Inc. | Process for preparation of microspheres and modification of release rate of core material |
HUT35524A (en) * | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
JPS60100516A (ja) * | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
DE3678308D1 (de) * | 1985-02-07 | 1991-05-02 | Takeda Chemical Industries Ltd | Verfahren zur herstellung von mikrokapseln. |
JPH0725689B2 (ja) * | 1986-10-07 | 1995-03-22 | 中外製薬株式会社 | 顆粒球コロニ−刺激因子を含有する徐放性製剤 |
DE3738228A1 (de) * | 1987-11-11 | 1989-05-24 | Hoechst Ag | Verfahren zur herstellung von bioabbaubaren mikrokapseln wasserloeslicher peptide und proteine sowie nach diesem verfahren erhaltene mikrokapseln |
JP2670680B2 (ja) * | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
JP3116311B2 (ja) * | 1990-06-13 | 2000-12-11 | エーザイ株式会社 | マイクロスフィアの製法 |
JPH0446115A (ja) * | 1990-06-13 | 1992-02-17 | Eisai Co Ltd | マイクロスフィアの製造法 |
JP3026228B2 (ja) * | 1990-11-30 | 2000-03-27 | アース製薬株式会社 | 徐放性製剤およびその製造方法 |
YU48420B (sh) * | 1991-03-25 | 1998-07-10 | Hoechst Aktiengesellschaft | Postupak za dobijanje biološki razgradljivih mikročestica sa dugotrajnim delovanjem |
GB9113158D0 (en) * | 1991-06-18 | 1991-08-07 | H H Robertson Uk Limited | Ventilators |
-
1992
- 1992-07-16 JP JP4189181A patent/JP2651320B2/ja not_active Expired - Lifetime
-
1993
- 1993-07-06 CA CA002099941A patent/CA2099941C/en not_active Expired - Fee Related
- 1993-07-12 US US08/089,194 patent/US5556642A/en not_active Expired - Lifetime
- 1993-07-14 TW TW082105608A patent/TW227988B/zh active
- 1993-07-15 KR KR1019930013341A patent/KR100211435B1/ko not_active IP Right Cessation
- 1993-07-16 DK DK93111455T patent/DK0586838T3/da active
- 1993-07-16 DE DE69315026T patent/DE69315026T2/de not_active Expired - Lifetime
- 1993-07-16 AT AT93111455T patent/ATE159854T1/de not_active IP Right Cessation
- 1993-07-16 ES ES93111455T patent/ES2110544T3/es not_active Expired - Lifetime
- 1993-07-16 EP EP93111455A patent/EP0586838B1/en not_active Expired - Lifetime
-
1997
- 1997-11-06 GR GR970402609T patent/GR3025297T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2651320B2 (ja) | 1997-09-10 |
CA2099941A1 (en) | 1994-01-17 |
DE69315026T2 (de) | 1998-03-26 |
CA2099941C (en) | 1999-12-28 |
DK0586838T3 (da) | 1998-07-27 |
TW227988B (es) | 1994-08-11 |
ATE159854T1 (de) | 1997-11-15 |
GR3025297T3 (en) | 1998-02-27 |
KR100211435B1 (ko) | 1999-08-02 |
JPH0632732A (ja) | 1994-02-08 |
EP0586838A1 (en) | 1994-03-16 |
DE69315026D1 (de) | 1997-12-11 |
KR940001882A (ko) | 1994-02-16 |
US5556642A (en) | 1996-09-17 |
EP0586838B1 (en) | 1997-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2110544T3 (es) | Procedimiento para la fabricacion de una preparacion a base de microesferas de liberacion sostenida. | |
US4479911A (en) | Process for preparation of microspheres and modification of release rate of core material | |
AU697887B2 (en) | Preparation of biodegradable microparticles containing a biologically active agent | |
Bayomi et al. | Preparation of casein–chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique | |
US5569468A (en) | Vaccine delivery system for immunization, using biodegradable polymer microspheres | |
US5650173A (en) | Preparation of biodegradable microparticles containing a biologically active agent | |
US4384975A (en) | Process for preparation of microspheres | |
WO2001028525A3 (en) | Method of producing sub-micron particles of biologically active agents | |
PT1017367E (pt) | Metodos para fabricar preparacoes de libertacao controlada baseadas em polimeros | |
EP0461630B1 (en) | Production process of microspheres | |
CA2187898A1 (fr) | Microspheres biodegradables a liberation controlee et leur procede de preparation | |
JP2000511110A (ja) | 超臨界流体を使用したマイクロカプセル化方法 | |
ES2187128T3 (es) | Nanocapsulas a base de polimeros anionicos hidrodispersables, su procedimiento de preparacion y composiciones cosmeticas y dermatologicas que las contienen. | |
Uchida et al. | Preparation and characterization of polylactic acid microspheres containing bovine insulin by aw/o/w emulsion solvent evaporation method | |
KR960700070A (ko) | 백신 제제(vaccine preparations) | |
EP3178471B1 (en) | Preparation method of drug-containing sustained release microparticles | |
EP2303237B1 (en) | Preparation method of biodegradable micro-particles containing drugs | |
Mandal et al. | Preparation of biodegradable microcapsules of zidovudine using solvent evaporation: effect of the modification of aqueous phase | |
IT1318404B1 (it) | Processo per la preparazione di formulazioni a rilascio accelerato conimpiego di fluidi compressi. | |
GB2310801A (en) | Process for removing an organic solvent from lactide-glycoside copolymer microspheres | |
Bodmeier et al. | Microencapsulation of antimicrobial ceftiofur drugs | |
RU95114533A (ru) | Фармацевтическая композиция замедленного высвобождения и способ ее получения | |
GB2303551A (en) | Polymer microparticles for drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 586838 Country of ref document: ES |